[go: up one dir, main page]

AR104209A1 - Formulación y contenedores de aerosol, inhaladores y similares que contienen la formulación - Google Patents

Formulación y contenedores de aerosol, inhaladores y similares que contienen la formulación

Info

Publication number
AR104209A1
AR104209A1 ARP160100948A ARP160100948A AR104209A1 AR 104209 A1 AR104209 A1 AR 104209A1 AR P160100948 A ARP160100948 A AR P160100948A AR P160100948 A ARP160100948 A AR P160100948A AR 104209 A1 AR104209 A1 AR 104209A1
Authority
AR
Argentina
Prior art keywords
formulation
aerosol
similars
inhalers
containers
Prior art date
Application number
ARP160100948A
Other languages
English (en)
Inventor
Seng Yap Eng
Pan Mei
Ling - Chen Yu
B Drake James
William Schultz David
Zhu Kewu
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Publication of AR104209A1 publication Critical patent/AR104209A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Otolaryngology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Reivindicación 1: Una composición que comprende albuterol en partículas o una sal farmacéuticamente aceptable o su solvato; ipratropio en partículas o una sal farmacéuticamente aceptable o su solvato; al menos uno de los siguientes: 1,1,1,2,3,3,3-heptafluoropropano y 1,1,1,2-tetrafluoro-etano. Reivindicación 13: Una lata de aerosol que comprende una composición de acuerdo con cualquiera de las reivindicaciones anteriores.
ARP160100948A 2015-04-10 2016-04-08 Formulación y contenedores de aerosol, inhaladores y similares que contienen la formulación AR104209A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562145838P 2015-04-10 2015-04-10

Publications (1)

Publication Number Publication Date
AR104209A1 true AR104209A1 (es) 2017-07-05

Family

ID=55755775

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160100948A AR104209A1 (es) 2015-04-10 2016-04-08 Formulación y contenedores de aerosol, inhaladores y similares que contienen la formulación

Country Status (4)

Country Link
US (1) US20180071231A1 (es)
EP (1) EP3280393A1 (es)
AR (1) AR104209A1 (es)
WO (1) WO2016164508A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3624771B1 (en) 2017-05-17 2023-11-15 Kindeva Drug Delivery L.P. Method of maintaining a water level in a pressurized aerosol canister.
EP3860580A4 (en) * 2018-10-01 2022-07-20 Kindeva Drug Delivery L.P. FORMULATION AND AEROSOL CARTRIDGES, INHALATORS AND THE LIKE CONTAINING THE FORMULATION
WO2020100040A1 (en) * 2018-11-12 2020-05-22 3M Innovative Properties Company Umeclidinium and vilanterol formulation and inhaler
CN114206317A (zh) * 2019-07-12 2022-03-18 金德瓦药物控释有限公司 气雾剂制剂、含有该制剂的罐和吸入器以及使用方法
US20230081910A1 (en) * 2020-02-28 2023-03-16 Kindeva Drug Delivery L.P. Inhaler
US11452474B1 (en) 2021-04-14 2022-09-27 Satio, Inc. Dual lever dermal patch system
US12023156B2 (en) 2021-10-13 2024-07-02 Satio, Inc. Dermal patch for collecting a physiological sample
US12178979B2 (en) 2021-10-13 2024-12-31 Satio, Inc. Dermal patch for delivering a pharmaceutical
US12214346B2 (en) 2021-10-13 2025-02-04 Satio, Inc. Dermal patch with a diagnostic test strip
US11964121B2 (en) 2021-10-13 2024-04-23 Satio, Inc. Mono dose dermal patch for pharmaceutical delivery
US12048543B2 (en) 2021-11-08 2024-07-30 Satio, Inc. Dermal patch for collecting a physiological sample with removable vial
US11877848B2 (en) 2021-11-08 2024-01-23 Satio, Inc. Dermal patch for collecting a physiological sample
US12053284B2 (en) 2021-11-08 2024-08-06 Satio, Inc. Dermal patch for collecting a physiological sample

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004224367B2 (en) * 2003-03-20 2009-10-08 Boehringer Ingelheim Pharmaceuticals, Inc. Formulation for a metered dose inhaler using hydro-fluoro-alkanes as propellants
US20060140873A1 (en) * 2004-12-27 2006-06-29 Chang Heng W Aerosol pharmaceutical compositions
DE102006053374A1 (de) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
US20120204871A1 (en) * 2011-02-10 2012-08-16 Julio Cesar Vega Stable, non-corrosive formulations for pressurized metered dose inhalers

Also Published As

Publication number Publication date
US20180071231A1 (en) 2018-03-15
EP3280393A1 (en) 2018-02-14
WO2016164508A1 (en) 2016-10-13

Similar Documents

Publication Publication Date Title
AR104209A1 (es) Formulación y contenedores de aerosol, inhaladores y similares que contienen la formulación
UY36121A (es) ?pirazolopiridinas y pirazolopirimidinas?.
MX392213B (es) Composiciones farmacéuticas que comprenden sales de glicopirrolato y 1,1-difluoroetano.
CL2016001889A1 (es) (2s)-n-[(1s)-1-ciano-2-feniletil]-1,4-oxazepan-2-carboxamidas como inhibidores de dipeptidil peptidasa 1.
UY36151A (es) ?una composición farmacéutica que comprende un inhibidor de fosfoinosítido 3-quinasa delta y un corticosteroide?.
DK3328843T3 (da) 1,3,4-oxadiazolsulfonamidderivat-forbindelser som histon- deacetylase-6-inhibitor, og den farmaceutske sammensætning
DK3330259T3 (da) 1,3,4-oxadiazolamidderivativ-forbindelse som histondeacetylase-6-inhibitor og farmaceutisk sammensætning indeholdende denne
NI201700020A (es) Compuestos de aminopirimidinilo como inhibidores de jak
CL2015002860A1 (es) Antagonistas de la alfa-v-beta-6 integrina
CL2015003569A1 (es) “compuestos derivados de (aril ó heteroaril)metil-2-(aril, heterociclil, cicloalquil ó alquil)-1,3-dioxan-metoxi-fenil-piperazin-1-il-fenil-heterociclil sustituido; composición farmacéutica que los comprende; su uso en el tratamiento de la fibrosis”. pct
BR112016030883A2 (pt) Dispositivo de aerossolização, e, métodos para dispensação de um medicamento aerossolizado e para uso de um dispositivo de aerossol.
CL2016002877A1 (es) Compuestos de 2-cloro-2-difluorometoxifenil pirazolopirimidina, composiciones y métodos de uso de los mismos.
MA46334A (fr) Composition pharmaceutique liquide
CO7111284A2 (es) Nucleósidos de espirooxetano de uracilo
CL2015000295A1 (es) Compuestos derivados de alquilpirimidina; composicion farmaceutica que los comprende; uso para el tratamiento de infecciones víricas y otras enfermedades.
CL2016001918A1 (es) Heteroaril amidas como inhibidores de agregación de proteína
CL2013002417A1 (es) Compuestos derivados de fluoropiridinona; composición farmacéutica que los comprende; y su uso en el tratamiento de infecciones bacterianas.
BR112016023620A2 (pt) frasco, sistema que compreende tal frasco e método para produção do mesmo
CL2018001510A1 (es) Composición farmacéutica que comprende un potente inhibidor de urat1
MX381970B (es) Derivado de sulfonamida y composición farmacéutica que contiene el mismo.
MX2022011896A (es) Composiciones oftalmicas.
CL2016001587A1 (es) Derivado basado en 1,2-naftoquinona y método de preparación del mismo.
BR112017016602A2 (pt) sistema e método de comunicação implementando um recipiente para um produto cosmético ou farmacêutico ou um vinho ou uma bebida alcoólica e dois dispositivos móveis de telecomunicação
MA43112A (fr) Pulvérisateur d'aérosol aseptique de dose unitaire
IT201800003376A1 (it) Struttura per il confezionamento di contenitori ad uso farmaceutico

Legal Events

Date Code Title Description
FB Suspension of granting procedure